BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6330664)

  • 41. Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressin.
    Puurunen J; Leppäluoto J
    Eur J Pharmacol; 1984 Sep; 104(1-2):145-50. PubMed ID: 6094207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. beta-Endorphin-(1-27) inhibits the spinal beta-endorphin-induced release of Met-enkephalin.
    Tseng LF; Li CH
    Int J Pept Protein Res; 1986 Apr; 27(4):394-7. PubMed ID: 2940195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-opiate beta-endorphin fragments and dopamine-V. gamma-Type endorphins and prolactin secretion in rats.
    Lamberts SW; de Quijada M; Van Ree JM; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1129-35. PubMed ID: 6184642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of water deprivation and administration of hypertonic saline on dopamine concentrations in posterior pituitary and vasopressin release in rats.
    Oki Y; Ohgo S; Yoshimi T
    Brain Res; 1985 Nov; 348(1):9-14. PubMed ID: 4063831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anterograde nerve degeneration after superior cervical ganglionectomy coexists with a decrease in arginine vasopressin release in rats.
    Romeo HE; Spinedi E; Esquifino AI; Estivariz F; Cardinali DP
    Neuroendocrinology; 1991 Oct; 54(4):346-52. PubMed ID: 1758576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release.
    Samson WK
    Neuroendocrinology; 1985 Mar; 40(3):277-9. PubMed ID: 3157876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of endorphins on cardiac responses during an emotional stress.
    Hagan JJ; Bohus B
    Physiol Behav; 1983 Nov; 31(5):607-14. PubMed ID: 6141580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of beta-endorphin fragments on plasma levels of vasopressin.
    van Wimersma Greidanus TB; van Ree JM; Goedemans HJ; van Dam AF; Andringa-Bakker EA; de Wied D
    Life Sci; 1981 Aug; 29(8):783-8. PubMed ID: 6272048
    [No Abstract]   [Full Text] [Related]  

  • 50. An investigation of the effects of interleukin-1 beta on plasma arginine vasopressin in the rat: role of adrenal steroids.
    Chover-Gonzalez AJ; Lightman SL; Harbuz MS
    J Endocrinol; 1994 Aug; 142(2):361-6. PubMed ID: 7931009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynorphin-A and vasopressin release in the rat: a structure-activity study.
    Van de Heijning BJ; Maigret C; Koekkoek-van den Herik I; Smelik WF; van Wimersma Greidanus TB
    Neuropeptides; 1994 Jun; 26(6):371-8. PubMed ID: 7936124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulsatile arginine vasopressin release from the rat hypothalamo neurohypophyseal system during osmotic stimulation.
    Ohno N
    Acta Med Okayama; 1981 Jun; 35(3):205-13. PubMed ID: 6457510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible opiate action in the anxiolytic and antinociceptive actions of alprazolam.
    Forman LJ; Estilow-Isabell S; Harwell M; De Salvo S; Cater J
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):259-71. PubMed ID: 2047572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation by leu-enkephalin of peptide release from perifused neurointermediate pituitary. I. Selective effect on potassium-, veratridine- and isoproterenol-stimulated secretion of vasopressin.
    Al Zein M; Lutz-Bucher B; Koch B
    Neuroendocrinology; 1984 Nov; 39(5):392-6. PubMed ID: 6096748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of central administration of the kappa-opiate receptor agonist U 69.593 on neurohypophyseal hormone levels in blood and cerebrospinal fluid.
    van Wimersma Greidanus TB; Janssen S; Frankhuijzen-Sierevogel JC; Maigret C; van de Heijning BJ
    Neuropeptides; 1996 Oct; 30(5):452-5. PubMed ID: 8923507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Failure to demonstrate natriuretic activity in the posterior pituitary after immunoneutralization of the vasopressin content.
    Ponec J; Földes O; Lichardus B
    Horm Metab Res; 1991 Oct; 23(10):473-5. PubMed ID: 1761277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral effects of the beta-endorphin fragment 2-9.
    van Ree JM; de Wied D
    Life Sci; 1982 Nov 15-22; 31(20-21):2383-6. PubMed ID: 6891738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. beta-Endorphin controls vasopressin release during foot shock-induced stress in the rat.
    Knepel W; Nutto D; Anhut H
    Regul Pept; 1983 Sep; 7(1):9-19. PubMed ID: 6316422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. mu- and K-opiate receptor agonists reduce plasma neurohypophysial hormone concentrations in water-deprived and normally hydrated rats.
    Evans RG; Olley JE; Rice GE; Abrahams JM
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):191-7. PubMed ID: 2541954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-expression of vasopressin with beta-endorphin and dynorphin in individual cells from the ovaries of Brattleboro and Long-Evans rats: immunocytochemical studies.
    Lolait SJ; Autelitano DJ; Markwick AJ; Toh BH; Funder JW
    Peptides; 1986; 7(2):267-76. PubMed ID: 2874549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.